Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension

Published:2006-09 Issue:9 Volume:55 Page:1159-1164
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Benndorf Ralf A.,Rudolph Tanja,Appel Daniel,Schwedhelm Edzard,Maas Renke,Schulze Friedrich,Silberhorn Elisabeth,Böger Rainer H.

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference23 articles.

1. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers;Kjeldsen;Am Heart J,2004

2. Prevention of type 2 diabetes mellitus through inhibition of the renin-angiotensin system;Scheen;Drugs,2004

3. Obesity and the metabolic syndrome in children and adolescents;Weiss;N Engl J Med,2004

4. The metabolic syndrome;Eckel;Lancet,2005

5. Angiotensin type 1 receptor blockers induce peroxisome proliferator–activated receptor-γ activity;Schupp;Circulation,2004

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sartans in the treatment of arterial hypertension: focus on telmisartan and azilsartan. A review;Terapevticheskii arkhiv;2023-11-03

2. Peroxisome proliferator-activated receptors as targets to treat metabolic diseases: Focus on the adipose tissue, liver, and pancreas;World Journal of Gastroenterology;2023-07-14

3. ER stress and inflammation crosstalk in obesity;Medicinal Research Reviews;2022-08-17

4. Telmisartan to reduce insulin resistance in HIV-positive individuals on combination antiretroviral therapy: the TAILoR dose-ranging Phase II RCT;Efficacy and Mechanism Evaluation;2019-07

5. Even Short-Term Telmisartan Treatment Ameliorated Insulin Resistance But Had No Influence on Serum Adiponectin and Tumor Necrosis Factor-Alpha Levels in Hypertensive Patients with Metabolic Syndrome;Metabolic Syndrome and Related Disorders;2019-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3